Affordable Access

Tracking the current rise of chinese pharmaceutical bionanotechnology.

Authors
  • Lenoir, Tim1
  • Herron, Patrick
Type
Published Article
Journal
Journal of biomedical discovery and collaboration
Publication Date
Oct 14, 2009
Volume
4
Pages
8–8
Identifiers
PMID: 19838996
Source
Medline
License
Unknown

Abstract

Since the implementation of the MLP, China has enjoyed a great deal of success producing bionano research findings while attracting a great deal of foreign investment from pharmaceutical corporations setting up advanced drug discovery operations. Given the combination of current scientific production growth as well as economic growth, a relatively low scientific capacity, and the ability of its policy to enhance such trends, China is in some sense already the new world leader in nanotechnology. Further, the Chinese national innovation system may be the new standard by which other national S&T policies should be measured.

Report this publication

Statistics

Seen <100 times